
Sex hormones’ role in neurological illnesses deserves greater scrutiny, JGH neurologist advises
Dr. Hyman Schipper says effects of sex hormones must be considered in treating epilepsy, migraine, strokes and other conditions.
Studies under way to use AI to identify seniors at risk for depression
AI program analyzes data about seniors’ daily routines to find patterns that point to the possibility of depression.
Mutations in breast cancer genes go undetected in certain breast cancer patients, study finds
Study’s findings make a case for universal genetic testing of breast cancer patients.
Name of pioneering HIV/AIDS researcher now adorns Centre for Viral Diseases
The McGill Centre for Viral Diseases in the LDI has been renamed in memory of Dr. Mark Wainberg, a pioneering HIV/AIDS researcher.
Combining diabetes medications reduces risk of certain adverse effects, study finds
Risk of adverse cardiovascular and renal events is lower when specific types of diabetes medication are combined, researchers say.
Watchful eyes for inquiring minds: Inside the Research Ethics Board
The Research Ethics Board plays a key role in ensuring the safety and ethical procedures of research that leads to medical innovation.
Researchers inch closer to better understanding of brain tumours in children
Certain brain cells may be inherently vulnerable to mutations that cause fatal brain tumours in children, says a study co-led by an LDI researcher.
Probing the benefits of exercise for patients and survivors of lymphoma
Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.
JGH expert on blood clots urges better training to prevent misdiagnosis of pulmonary embolism
Dr. Susan Kahn of the JGH Centre of Excellence in Thrombosis and Anticoagulation Care is calling for better training to prevent misdiagnosis of pulmonary embolism.
Researchers identify protective gene variant against COVID-19
A global study, in which the LDI participated, has identified a specific gene variant that protects against severe infection by COVID-19.